What are IL-5 inhibitor drugs?

IL-5 inhibitor drugs are pharmacologic agents that share a common mechanism (typically targeting IL-5). 0 are currently marketed, with 2 more in clinical development.

IL-5 inhibitor

0 marketed 2 in Phase 3

This page covers all IL-5 inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting IL-5.

Targets

IL-5

Phase 3 pipeline (2)

Placebo matching mepolizumab · GlaxoSmithKline · Immunology
Mepolizumab is an IL-5 inhibitor, which works by binding to the IL-5 protein and preventing it from interacting with its receptor on the surface of eosinophils, thereby reducing eosinophilic inflammation.
Placebo to Mepolizumab · AstraZeneca · Immunology
Mepolizumab is an interleukin-5 (IL-5) inhibitor that blocks the action of IL-5, a cytokine involved in the production and survival of eosinophils.